TEXAS INSTRUMENTS INCTXN

Texas Instruments executed a massive manufacturing expansion through a severe cyclical downturn, maintaining $4.82 billion in capital expenditures in FY2024 even as revenue contracted by 10.7%. This contrarian strategy forms the core investment thesis: by absorbing short-term margin pain to build 300mm wafer capacity, the company is structurally positioned to capture outsized free cash flow as industrial and automotive markets recover.

The top line highlighted this deep industry cyclicality, with revenue ultimately shifting from $18.34 billion in FY2021 to $17.68 billion in FY2025. The Analog segment remains the primary engine, contributing 79% of total revenue in FY2025. Profitability compressed significantly during the heavy investment phase, driving gross margins down from a peak of 68.8% in FY2022 to 58.1% in FY2024 due to factory underutilization. However, operational leverage is returning. Free cash flow generation rebounded to $2.94 billion in FY2025, representing 16.6% of revenue, while a pending $7.5 billion acquisition of Silicon Labs signals accelerated expansion in embedded processing.

Investors have largely looked past the cyclical trough to value the company's long-term capacity advantages. At the close of FY2025, the stock traded at $173.49 with a 31.8x price-to-earnings multiple. This valuation is anchored by a relentless capital return program, which delivered $6.48 billion to shareholders via dividends and repurchases during FY2025 alone.